A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

BACKGROUND: Androgens are key regulators of prostate gland maintenance and prostate cancer growth, and androgen deprivation therapy has been the mainstay of treatment for advanced prostate cancer for many years. A long-standing hypothesis has been that inherited variation in the androgen receptor (A...

Full description

Bibliographic Details
Main Authors: Lindström, S, Ma, J, Altshuler, D, Giovannucci, E, Riboli, E, Albanes, D, Allen, N, Berndt, S, Boeing, H, Bueno-de-Mesquita, H, Chanock, S, Dunning, A, Feigelson, H, Gaziano, J, Haiman, C, Hayes, R, Henderson, B, Hunter, D, Kaaks, R, Kolonel, L, Le Marchand, L, Martínez, C, Overvad, K, Siddiq, A, Stampfer, M
Format: Journal article
Language:English
Published: 2010

Similar Items